Product Information

METHIMAZOLE 5 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.0706 per EA under NDC 69452032820. Its NADAC has been published 119 times since Aug 14, 2024.

FDA first approved this application on Sep 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHIMAZOLE 5 MG TABLET

methimazole
$0.0706per EA

Strength

5 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452032820

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METHIMAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA218149

FDA Approved

9/25/2023

TE Code

AB

On Market Since

3/25/2024

Pharmacological Classes

Thyroid Hormone Synthesis Inhibitor
Thyroid Hormone Synthesis Inhibitors

Price Statistics

The NADAC for METHIMAZOLE 5 MG TABLET has been published 119 times since Aug 14, 2024, and over the history we have for it it has risen 2.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0706 per EA
All-time high$0.0864 (Sep 10, 2025)
All-time low$0.0661 (Nov 20, 2024)
52-week high$0.0788
52-week low$0.0694
Median price$0.0743
Average price$0.0751
Largest weekly change+15.6% (Aug 21, 2024)
Weeks tracked119
Tracking sinceAug 14, 2024

Price History

1W

+1.7%

1M

+1.7%

3M

-0.2%

6M

-2.0%

1Y

-10.5%

3Y

N/A

5Y

N/A

All

+2.4%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHIMAZOLE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 5 MG TABLET, manufactured by Bionpharma Inc., is $0.0706 per EA (NDC 69452032820), effective Nov 18, 2026.

How has the price of METHIMAZOLE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHIMAZOLE 5 MG TABLET has risen 2.4%. It has been tracked across 119 weekly CMS publications since Aug 14, 2024.

What are the highest and lowest recorded NADAC prices for METHIMAZOLE 5 MG TABLET?

Since Aug 14, 2024, the NADAC for METHIMAZOLE 5 MG TABLET has ranged from a low of $0.0661 (Nov 20, 2024) to a high of $0.0864 (Sep 10, 2025), with a median of $0.0743 per EA.

Are there cheaper alternatives to METHIMAZOLE 5 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHIMAZOLE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHIMAZOLE 5 MG TABLET?

METHIMAZOLE 5 MG TABLET (NDC 69452032820) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.